What Researchers Did
This systematic review and meta-analysis assessed the efficacy of hyperbaric oxygen therapy (HBOT) in postoperative intracranial aneurysm patients by analyzing 11 randomized controlled trials.
What They Found
Analyzing 11 randomized controlled trials with 2,268 patients, researchers found that hyperbaric oxygen therapy significantly improved clinical treatment efficacy (RR = 1.19, 95% CI: 1.11-1.28). Adjunctive HBOT also significantly enhanced neurological recovery, functional outcomes, and overall quality of life in these patients.
What This Means for Canadian Patients
Canadian patients recovering from intracranial aneurysm surgery may experience improved neurological recovery and quality of life if hyperbaric oxygen therapy is adopted as an adjunctive treatment. This could lead to better functional outcomes and a more complete recovery post-surgery.
Canadian Relevance
This study does not have a specific Canadian connection or focus.
Study Limitations
The abstract indicates that additional high-quality, multicenter studies are necessary to confirm these findings.